Journalists: For links to video and audio files, see the bottom of this post.
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa, a Mayo Clinic researcher has shown. Steroids attached to the dendrimers targeted only damage-causing cells, leaving the rest of eye unaffected and preserving vision.
“We’ve developed an intracellular, sustained-release drug delivery system,” says lead author Raymond Iezzi, M.D., a Mayo Clinic ophthalmologist. Dr. Iezzi conducted the research in part at Wayne State University’s Kresge Eye Institute, and collaborated with scientists from Wayne State’s College of Engineering and Ligon Research Center of Vision. The study, performed in rats, appears in the journal Biomaterials.
Journalists: The following video and audio clips with Dr. Iezzi explaining the process are available for download and use in your stories.
Below is a link to a youtube video with Dr. Iezzi that you can embed with your stories.